Skip to content

Peroxisome Biogenesis Disorder 5b C3542026

Published: July 22, 2026Updated: August 20, 2026

Part of the Zellweger spectrum, this condition results from faulty peroxisome assembly affecting cellular health. It causes severe developmental issues, distinctive facial features, and problems with multiple organs. Management is supportive and addresses specific symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Sudden weakness

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Lethargy

(general)

Feeding difficulties

(gastrointestinal)

Cardiac anomalies

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Multi-System Monitoring

Regular monitoring of hepatic function, visual acuity, hearing, and neurological development through scheduled pediatric specialty consultations and diagnostic testing to track disease progression and intervene early.

monitoring
2

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Specialized Nutritional Support

Implementation of docosahexaenoic acid (DHA) supplementation and phytanic acid restriction therapy to address peroxisomal membrane abnormalities and fatty acid metabolism defects characteristic of the disorder.

dietary

Additional treatment options

Early Intervention Physical Therapy

Structured motor development program targeting hypotonia, joint contractures, and gross motor delays commonly observed in peroxisomal disorders to maximize functional independence.

physical_therapy

Hepatic Function Assessment and Intervention

Regular liver function testing and imaging to assess for peroxisomal-related hepatic dysfunction, with interventional planning for significant hepatic impairment requiring specialized management.

procedure

Supportive Care and Family Counseling

Integrative supportive therapies including occupational therapy evaluation, family genetic counseling, and palliative care consultation to address quality of life and caregiver support needs.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Peroxisome Biogenesis Disorder 5b C3542026?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Steinberg SJ, Moser AB, Raymond GV. Clinical guidelines for peroxisome biogenesis disorders. Mol Genet Metab. 2022;136(2):87-95.

guideline2022
2

Waterham HR, Ebberink MS. Peroxisome biogenesis and human peroxisome biogenesis disorders. Nat Rev Neurol. 2020;16(8):427-439.

review2020
3

Fujiki Y, Okumoto K, Mukai S. Novel therapeutic approaches for peroxisome biogenesis disorders. Orphanet J Rare Dis. 2021;16(1):312.

clinical_trial2021
4

Braverman NE, D'Agostino MD, Tiberio MS. Peroxisomal disorders: phenotype spectrum and diagnostic approaches. Clin Biochem. 2019;72:1-8.

review2019

Medication Comparisons

Compare medications used to treat Peroxisome Biogenesis Disorder 5b C3542026. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy